Norfloxacino Sandoz 400 mg comprimidos EFG
SURVIC_STUDY
Approved small_molecule active
Quick answer
Norfloxacino Sandoz 400 mg comprimidos EFG for Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less. is a Approved program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less.
- Phase
- Approved
- Modality
- small_molecule
- Status
- active